Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 41 (KRT8P41) is a processed pseudogene derived from the keratin 8 gene (KRT8), which in its functional form encodes an intermediate filament protein expressed primarily in simple epithelial cells. Pseudogenes like KRT8P41 are the result of gene duplication or retrotransposition events and typically lack a protein-coding function due to sequence disruptions or loss of regulatory elements. KRT8P41 is not expressed as a functional protein, does not participate in cellular pathways, and is not associated with any known therapeutic intervention, disease roles, or biomarker use. It is classified within the broader keratin pseudogene family, reflecting human genetic complexity and evolutionary history[1][6]. Key contextual notes: - Keratin pseudogenes, including KRT8P41, do not encode proteins and are considered nonfunctional remnants of ancient keratin genes[1][6]. - KRT8P41 should not be confused with the functional keratin 8 gene (KRT8), which plays important biological roles; pseudogenes like KRT8P41 have lost protein-coding capability and do not serve as receptors, enzymes, or drug targets. - There are many processed keratin pseudogenes in the human genome, dispersed throughout, with no intact reading frames[1][6]. - Current evidence does not identify any therapeutic application, disease association, or experimental drug interaction for KRT8P41. Summary: KRT8P41 (Keratin 8 pseudogene 41) is a pseudogene, not a functional genomic target, receptor, or protein, and has no recognized biological role, disease linkage, or druggability[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 41 (KRT8P41).